Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 9, 1997

View Archived Issues

NK1 antagonist effective in rat model of focal cerebral ischemia

Attenuation of cyclophosphamide-induced bladder damage in animals by GR-203040

Inflazyme contracts Inveresk Research for IND support

New orally active immunosuppressant for combination with ciclosporin

Additional results for Bradycor in traumatic brain injury

Kosan receives NIH grant for macrolide antibiotic development

Schering-Plough seeks approval for pediatric indication of Intron A

Novastan granted priority review status by FDA

Preliminary results reported for RMP-7/carboplatin

Promising phase II results for Genzyme Transgenics' rhATIII

Pharmacia & Upjohn's urinary incontinence treatment approved in Sweden

Agents useful for BPH from Pfizer

Warner-Lambert/CoCensys develop neuroprotective agents

Osteoprotegerin: new polypeptide for bone diseases

Ribi seeks approval for melanoma vaccine in Canada

Ethnic differences in codeine's efficacy/side effects

Copaxone approved in Canada

SB-204269, an anticonvulsant with a unique mechanism of action

Resveratrol found in edible peanuts

RPR submits NDA for novel antibiotic

Nepicastat: a novel dopamine-beta-hydroxylase inhibitor for CHF

GSH prevents cisplatin-induced toxicity

Treatment for preleukemic disorder from Milkhaus enters phase III

Effects of AE-0047 on lipid profiles

CDR Therapeutics and CellGenEx merge to form Xcyte Therapies

(S)-(-)-OSU-6162 effective in monkey model of Parkinson's disease

Tolmetin eyedrop formulation evaluated in rabbits

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...